NO20042564L - 2-aryl-propionsyrer og farmasoytiske sammensetninger som inneholder disse - Google Patents
2-aryl-propionsyrer og farmasoytiske sammensetninger som inneholder disseInfo
- Publication number
- NO20042564L NO20042564L NO20042564A NO20042564A NO20042564L NO 20042564 L NO20042564 L NO 20042564L NO 20042564 A NO20042564 A NO 20042564A NO 20042564 A NO20042564 A NO 20042564A NO 20042564 L NO20042564 L NO 20042564L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- aryl
- interleukin
- branched
- chemotaxis
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004890 Interleukin-8 Human genes 0.000 abstract 6
- 108090001007 Interleukin-8 Proteins 0.000 abstract 6
- -1 benzoylamino, benzenesulfonyloxy, benzenesulfonylamino, benzenesulfonylmethyl Chemical group 0.000 abstract 6
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 abstract 6
- 229940096397 interleukin-8 Drugs 0.000 abstract 6
- 239000003112 inhibitor Substances 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 230000035605 chemotaxis Effects 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000004442 acylamino group Chemical group 0.000 abstract 2
- 210000000440 neutrophil Anatomy 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- DHFSUPPYOBITGY-UHFFFAOYSA-N 2-(3-propan-2-ylphenyl)propanoic acid Chemical compound CC(C)C1=CC=CC(C(C)C(O)=O)=C1 DHFSUPPYOBITGY-UHFFFAOYSA-N 0.000 abstract 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 102000016950 Chemokine CXCL1 Human genes 0.000 abstract 1
- 108010014419 Chemokine CXCL1 Proteins 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 102000002791 Interleukin-8B Receptors Human genes 0.000 abstract 1
- 108010018951 Interleukin-8B Receptors Proteins 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000002456 anti-arthritic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000002682 anti-psoriatic effect Effects 0.000 abstract 1
- 230000003356 anti-rheumatic effect Effects 0.000 abstract 1
- 230000000767 anti-ulcer Effects 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 210000001616 monocyte Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/67—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
- C07C59/135—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/04—Monocyclic monocarboxylic acids
- C07C63/06—Benzoic acid
- C07C63/08—Salts thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI002434A ITMI20012434A1 (it) | 2001-11-20 | 2001-11-20 | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
| PCT/EP2002/012939 WO2003043625A1 (en) | 2001-11-20 | 2002-11-19 | 2-aryl-propionic acids and pharmaceutical compositions containing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20042564L true NO20042564L (no) | 2004-06-18 |
| NO334286B1 NO334286B1 (no) | 2014-01-27 |
Family
ID=27638512
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042564A NO334286B1 (no) | 2001-11-20 | 2004-06-18 | (R,S)-2-aryl-propionsyreforbindelser, fremgangsmåte for fremstilling og anvendelse av slike, samt farmasøytisk sammensetning innholdende (R,S)-2-arylpropionsyreforbindelser. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8063242B2 (no) |
| EP (2) | EP1455773B1 (no) |
| JP (1) | JP4549674B2 (no) |
| KR (2) | KR101060064B1 (no) |
| CN (1) | CN100376242C (no) |
| AT (1) | ATE447401T1 (no) |
| AU (1) | AU2002352052B2 (no) |
| BR (1) | BRPI0214322B1 (no) |
| CA (1) | CA2465375C (no) |
| DE (1) | DE60234272D1 (no) |
| DK (2) | DK2229942T3 (no) |
| ES (2) | ES2333943T3 (no) |
| HK (1) | HK1075014A1 (no) |
| HU (1) | HU229077B1 (no) |
| IL (2) | IL161767A0 (no) |
| IT (1) | ITMI20012434A1 (no) |
| MX (1) | MXPA04004744A (no) |
| NO (1) | NO334286B1 (no) |
| NZ (1) | NZ532705A (no) |
| PL (1) | PL209745B1 (no) |
| PT (2) | PT1455773E (no) |
| RU (1) | RU2317075C2 (no) |
| SI (1) | SI1455773T1 (no) |
| WO (1) | WO2003043625A1 (no) |
| ZA (1) | ZA200403436B (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20010395A1 (it) | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
| EP1457485A1 (en) * | 2003-03-14 | 2004-09-15 | Dompé S.P.A. | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| CA2553705C (en) | 2004-03-23 | 2012-12-11 | Dompe S.P.A. | 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| SI2024329T1 (sl) * | 2006-05-18 | 2014-01-31 | Dompe' S.P.A. | (2r)-2-((4-sulfonil)aminofenil)propanamidi in farmacevtski sestavki, ki jih vsebujejo |
| WO2009018447A2 (en) * | 2007-07-31 | 2009-02-05 | New York University | Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions |
| CN101959429B (zh) * | 2008-01-08 | 2014-09-10 | 阿克塞利亚制药公司 | 抗微生物肽系统的激动剂 |
| EP2166006A1 (en) | 2008-09-18 | 2010-03-24 | Dompe' S.P.A. | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| CN101416961B (zh) * | 2008-11-21 | 2012-02-15 | 合肥金科生物医药科技有限公司 | 一种苯丙酸类药物光学异构体及其制药用途 |
| KR101923354B1 (ko) * | 2009-05-04 | 2018-11-28 | 프로메틱 파마 에스엠티 리미티드 | 치환된 방향족 화합물 및 그의 약학적 용도 |
| MY162420A (en) | 2010-10-27 | 2017-06-15 | Prometic Pharma Smt Ltd | Compounds and compositions for the treatment of cancer |
| DE102011119821A1 (de) | 2011-12-01 | 2013-06-06 | Bundesdruckerei Gmbh | Elektrooptisches Sicherheitselement |
| TWI742541B (zh) | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
| BR112017002060A2 (pt) * | 2014-07-31 | 2017-12-26 | Glaxosmithkline Ip Dev Ltd | novo uso |
| CN108794319B (zh) * | 2018-07-10 | 2021-01-15 | 艾希尔（深圳）药物研发有限公司 | 一种布洛芬杂质a的制备方法 |
| CN110038000A (zh) * | 2019-04-10 | 2019-07-23 | 徐州医科大学 | Dat在制备预防或治疗肠炎及相关疾病或症状的药物中的应用 |
| CN112778167A (zh) * | 2019-11-01 | 2021-05-11 | 邵阳学院 | 一种快速制备n-苯磺酰基氨基酸酯类化合物的方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE621255A (no) | ||||
| NL137301C (no) * | 1966-03-30 | |||
| US3629320A (en) * | 1969-04-09 | 1971-12-21 | Geigy Chem Corp | 2-(4-halo- and 4-trifluoromethylphenylsulfonamido)phenylacetic acids and esters thereof |
| GB1308327A (en) * | 1970-04-14 | 1973-02-21 | Reckitt & Colmann Prod Ltd | Phenylalkane derivatives and processes for the preparation thereof |
| ES415446A1 (es) | 1973-06-01 | 1976-02-16 | Gallardo Antonio Sa | Un procedimiento para la obtencion de derivados de acidos m-benzoilfenil alcanoicos. |
| JPS5111748A (en) | 1974-07-16 | 1976-01-30 | Taisho Pharmaceutical Co Ltd | Suchirubenjudotaino seizoho |
| JPS582934B2 (ja) | 1974-07-29 | 1983-01-19 | ニツシンセイフン カブシキガイシヤ | ２−（置換アリ−ル）−プロピオン酸の製法 |
| FR2316211A1 (fr) * | 1975-07-04 | 1977-01-28 | Dick Pierre | Nouveau mode d'acces a des derives d'acides phenyl carboxyliques |
| JPS5283822A (en) * | 1976-01-01 | 1977-07-13 | Ikeda Mohando Co | Naphthylaminopheny acetic acid derivatives and salts thereof* |
| JPS537640A (en) * | 1976-07-09 | 1978-01-24 | Teikoku Hormone Mfg Co Ltd | Synthesis of diphenylamine derivatives |
| US4465855A (en) * | 1978-05-23 | 1984-08-14 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt | Process for the preparation of arylacetic acid derivatives |
| JPS58194814A (ja) * | 1982-05-11 | 1983-11-12 | Nippon Shinyaku Co Ltd | 免疫調節作用を有する薬剤 |
| IT1207994B (it) * | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
| IT1230752B (it) | 1989-02-17 | 1991-10-29 | Boehringer Biochemia Srl | Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura. |
| US4940813A (en) | 1989-03-31 | 1990-07-10 | Merck & Co., Inc. | Resolution of a carboxylic acid |
| US6160018A (en) * | 1995-03-13 | 2000-12-12 | Loma Linda University Medical Center | Prophylactic composition and method for alzheimer's Disease |
| US5981592A (en) * | 1995-03-13 | 1999-11-09 | Loma Linda University Medical Center | Method and composition for treating cystic fibrosis |
| US5862341A (en) | 1996-07-03 | 1999-01-19 | Net Manage, Inc. | Screen identification method |
| IT1283649B1 (it) | 1996-08-02 | 1998-04-23 | Dompe Spa | Procedimento per la preparazione di acidi 2-aril-propionici e 2-aril-acetici a partire da aril-olefine |
| US6214881B1 (en) | 1996-08-21 | 2001-04-10 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| KR100220645B1 (ko) | 1997-07-04 | 1999-09-15 | 구광시 | 벤젠유도체의 제조방법 |
| IT1298214B1 (it) | 1998-01-28 | 1999-12-20 | Dompe Spa | Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche. |
| JP5144861B2 (ja) * | 1998-07-27 | 2013-02-13 | エミスフェアー・テクノロジーズ・インク | 活性剤のデリバリーのための化合物及び組成物 |
| IT1303249B1 (it) | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| DE19907895A1 (de) | 1999-02-24 | 2000-11-16 | Paz Arzneimittelentwicklung | Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen bei Mensch und Tier, welche durch die Hemmung der Aktivierung von NF-kB therapeutisch beeinflußt werden können |
| AUPP975699A0 (en) * | 1999-04-14 | 1999-05-06 | Futurepump Ltd | Vacuum apparatus |
| IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
-
2001
- 2001-11-20 IT IT2001MI002434A patent/ITMI20012434A1/it unknown
-
2002
- 2002-11-19 KR KR1020107017598A patent/KR101060064B1/ko active IP Right Grant
- 2002-11-19 AT AT02787726T patent/ATE447401T1/de active
- 2002-11-19 US US10/495,365 patent/US8063242B2/en not_active Expired - Fee Related
- 2002-11-19 EP EP02787726A patent/EP1455773B1/en not_active Expired - Lifetime
- 2002-11-19 AU AU2002352052A patent/AU2002352052B2/en not_active Ceased
- 2002-11-19 IL IL16176702A patent/IL161767A0/xx not_active IP Right Cessation
- 2002-11-19 EP EP09174797A patent/EP2229942B1/en not_active Expired - Lifetime
- 2002-11-19 RU RU2004118605/15A patent/RU2317075C2/ru not_active IP Right Cessation
- 2002-11-19 PT PT02787726T patent/PT1455773E/pt unknown
- 2002-11-19 JP JP2003545306A patent/JP4549674B2/ja not_active Expired - Fee Related
- 2002-11-19 PL PL370585A patent/PL209745B1/pl unknown
- 2002-11-19 HU HU0600336A patent/HU229077B1/hu not_active IP Right Cessation
- 2002-11-19 ES ES02787726T patent/ES2333943T3/es not_active Expired - Lifetime
- 2002-11-19 NZ NZ532705A patent/NZ532705A/en not_active IP Right Cessation
- 2002-11-19 KR KR1020047007591A patent/KR101015003B1/ko active IP Right Grant
- 2002-11-19 PT PT91747972T patent/PT2229942E/pt unknown
- 2002-11-19 CN CNB028270290A patent/CN100376242C/zh not_active Expired - Fee Related
- 2002-11-19 DK DK09174797.2T patent/DK2229942T3/da active
- 2002-11-19 WO PCT/EP2002/012939 patent/WO2003043625A1/en active Application Filing
- 2002-11-19 DK DK02787726.5T patent/DK1455773T3/da active
- 2002-11-19 BR BRPI0214322A patent/BRPI0214322B1/pt not_active IP Right Cessation
- 2002-11-19 ES ES09174797T patent/ES2393589T3/es not_active Expired - Lifetime
- 2002-11-19 DE DE60234272T patent/DE60234272D1/de not_active Expired - Lifetime
- 2002-11-19 MX MXPA04004744A patent/MXPA04004744A/es active IP Right Grant
- 2002-11-19 CA CA2465375A patent/CA2465375C/en not_active Expired - Fee Related
- 2002-11-19 SI SI200230862T patent/SI1455773T1/sl unknown
-
2004
- 2004-05-06 ZA ZA2004/03436A patent/ZA200403436B/en unknown
- 2004-06-18 NO NO20042564A patent/NO334286B1/no not_active IP Right Cessation
-
2005
- 2005-10-14 HK HK05109113A patent/HK1075014A1/xx not_active IP Right Cessation
-
2011
- 2011-11-09 IL IL216230A patent/IL216230A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL216230A0 (en) | 2-aryl-propionic acids and pharmaceutical compositions containing them | |
| MY142177A (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
| ECSP055847A (es) | Derivados de dihidropiranoindol-3,4-diona sustituidos y derivados de 2-hidroximetilindol del ácido 3-oxoacético sustituidos como inhibidores del inhibidor del activador de plasminógeno 1 (pai-1) | |
| AR063569A1 (es) | Derivados de benzil- benzonitrilo sustituidos con glucopiranosilo medicamentos que contienen a compuestos de este tipo su uso u procedimiento para su fabricacion | |
| AR061980A1 (es) | Acilanilidas sustituidas y metodos para su utilizacion | |
| PE20070593A1 (es) | Compuestos pirrolopirimidina como inhibidores de syk | |
| AR040409A1 (es) | Inhibidores de histona desacetilasa | |
| AR061846A1 (es) | Compuestos heteroaromaticos de azol inhibidores selectivos de la pde10a, composiciones farmaceuticas que los contienen y usos para tratar trastornos asociados al cns. | |
| ATE444286T1 (de) | 2-phenylpropionsäurederivate und diese enthaltende pharmazeutische zusammensetzung | |
| EA200800352A1 (ru) | Производные пирролопиридина и их применение в качестве модуляторов ppar-рецепторов | |
| EA201000805A1 (ru) | Бис-(сульфониламино)производные в терапии 066 | |
| BRPI0506622A (pt) | éster biciclo derivado; um intermediário na produção do éster biciclo derivado; produto farmacêutico contendo um ingrediente ativo do éster biciclo derivado; inibidor dpp-iv contendo um ingrediente ativo do éster biciclo derivado; agente terapêutico para uma doença envolvendo dpp-iv contendo um ingrediente ativo do éster biciclo derivado, e agente terapêutico | |
| BR0210468A (pt) | Derivados 6-(aril-amido ou aril-amidometil)-naftalen-2-ilóxi-acìdicos como inibidores de inibidor de ativador de plasminogênio tipo-1 (pai-1) | |
| NI200800227A (es) | Acidos 1,3-dioxano carboxilicos | |
| NZ510207A (en) | Method for treating atherosclerosis employing an aP2 inhibitor | |
| FR2892413B1 (fr) | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique | |
| NO20051011L (no) | Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister | |
| AR115303A1 (es) | Moduladores de calpaína y usos terapéuticos de los mismos | |
| UA89067C2 (ru) | Производные гидантоина, полезные как ингибиторы металлопротеиназ | |
| AR044453A1 (es) | Derivados de metoxi-pirazin-tienil sulfonamida | |
| MEP34708A (en) | Macrolide-conjugates with anti-inflammatory activity | |
| ES2396764B1 (es) | FÁRMACOS INHIBIDORES DE p38 Y APLICACIONES. | |
| El Bialy et al. | Current progress in antifibrotics | |
| ATE470664T1 (de) | Hydroxamsäurederivate | |
| RU2785715C1 (ru) | ПРИМЕНЕНИЕ МОНОЦИКЛИЧЕСКОГО β-ЛАКТАМНОГО СОЕДИНЕНИЯ В ФАРМАЦИИ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: DOMPE FARMACEUTICI S.P.A., IT |
|
| MM1K | Lapsed by not paying the annual fees |